Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events

被引:192
|
作者
Yarur, Andres J. [2 ]
Deshpande, Amar R. [1 ]
Pechman, David M. [2 ]
Tamariz, Leonardo [2 ]
Abreu, Maria T. [1 ]
Sussman, Daniel A. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Div Gastroenterol, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2011年 / 106卷 / 04期
关键词
CORONARY-HEART-DISEASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; RISK-FACTOR; INDEPENDENT PREDICTOR; LEUKOCYTE COUNT; GLUCOCORTICOIDS; ATHEROSCLEROSIS; COMPLICATIONS;
D O I
10.1038/ajg.2011.63
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Patients with inflammatory bowel disease (IBD) present with several extraintestinal manifestations, including systemic inflammation and hypercoagulability. Limited studies have shown that patients with IBD may have a higher risk of developing atherosclerosis. The incidence of coronary artery disease (CAD) and the role of traditional CAD risk factors in IBD patients remain unclear. We sought to compare the rates of CAD events in patients with IBD with matched controls. METHODS: We performed a longitudinal cohort study of patients with IBD compared with matched controls. The primary outcome was the development of CAD events. Traditional and nontraditional CAD risk factors were assessed. Cox proportional hazards model was used to assess the impact of each CAD risk factor on the outcomes. RESULTS: A total of 356 IBD patients and 712 matched controls were followed for a median of 53 and 51 months, respectively. The unadjusted hazard ratio (HR) for developing CAD in the IBD group was 2.85 (95% confidence interval (CI) 1.82-4.46). IBD patients had significantly lower rates of selected traditional CAD risk factors (hypertension, diabetes, dyslipidemia, and obesity; P < 0.01 for all). Adjusting for these factors, the HR for developing CAD between groups was 4.08 (95 % CI 2.49-6.70). Among nontraditional risk factors, an elevated white blood cell (WBC) count was a risk factor for CAD development in the IBD group (HR 1.23; 95 % CI 1.15-1.33). CONCLUSIONS: An increased incidence of CAD events was noted in IBD patients despite having a lower burden of traditional risk factors. Additionally, these risk factors had a lower impact on CAD development in the IBD group. Further investigation into how nontraditional risk factors, including WBC count, and the effect of attenuating systemic inflammation in IBD patients change CAD risk is warranted.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 50 条
  • [21] Increased incidence of matrix metalloproteinases in the urine of patients with inflammatory bowel disease
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (04): : 555 - 555
  • [22] Increased incidence of inflammatory bowel disease in Quebec residents with airway diseases
    Brassard, Paul
    Vutcovici, Maria
    Ernst, Pierre
    Patenaude, Valerie
    Sewitch, Maida
    Suissa, Samy
    Bitton, Alain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (04) : 962 - 968
  • [23] Toxic Megacolon Not Associated With Inflammatory Bowel Disease is Associated With Increased Mortality
    Gunderson, Joseph
    Schaub, David
    Tumac, Alisia C.
    Borgstrom, Mark
    Taleban, Sasha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1033 - S1033
  • [24] Disease Activity Is Associated With Increased Bacterial Diversity in Inflammatory Bowel Disease
    Docktor, Michael
    Wang, Yaoyu
    Abramowicz, Shelly
    Weber, Sarah
    Boisvert, Heike
    Duncan, Margaret
    Bousvaros, Athos
    Paster, Bruce
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S63 - S63
  • [25] Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review
    Jaiswal, Vikash
    Batra, Nitya
    Dagar, Mehak
    Butey, Swatika
    Huang, Helen
    Chia, Jia Ee
    Naz, Sidra
    Endurance, Evbayekha O.
    Raj, Nishchita
    Patel, Srushti
    Maroo, Dipansha
    Ang, Song Peng
    Hanif, Muhammed
    Mukherjee, Dattatreya
    Sarfraz, Zouina
    Shrestha, Abhigan Babu
    Song, David
    MEDICINE, 2023, 102 (06)
  • [26] INFLAMMATORY BOWEL DISEASE AND ASSOCIATED CARDIOVASCULAR DISEASE OUTCOMES: A SYSTEMATIC REVIEW
    Naz, Sidra
    Butey, Swatika
    Jaiswal, Vikash
    Dagar, Mehak
    Huang, Helen
    Chia, Jia Ea
    Endurance, Evbayekha O.
    Raj, Nishchita
    Patel, Srushti
    Maroo, Dipansha
    Mukherjee, Dattatreya
    Hanif, Muhammad
    GASTROENTEROLOGY, 2023, 164 (04) : S32 - S32
  • [27] INFLAMMATORY BOWEL DISEASE AND ASSOCIATED CARDIOVASCULAR DISEASE OUTCOMES: A SYSTEMATIC REVIEW
    Naz, Sidra
    Butey, Swatika
    Jaiswal, Vikash
    Dagar, Mehak
    Huang, Helen
    Chia, Jia Ee
    Endurance, Evbayekha O.
    Raj, Nishchita
    Patel, Srushti
    Maroo, Dipansha
    Mukherjee, Dattatreya
    Hanif, Muhammad
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S25 - S25
  • [28] Disease severity in patients with inflammatory bowel disease associated with cardiovascular diseases
    Mantaka, A.
    Tsoukali, E.
    Fragaki, M.
    Karmiris, K.
    Viazis, N.
    Mantzaris, G.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S521 - S521
  • [29] Are Patients With Inflammatory Bowel Diseases at Increased Risk for Cardiovascular Disease? Reply
    Singh, Siddharth
    Singh, Harkirat
    Loftus, Edward V., Jr.
    Pardi, Darrell S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) : 2135 - 2135
  • [30] ADVERSE EVENTS ASSOCIATED WITH THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN GERMANY
    Wilke, T.
    Groth, A.
    Long, G. H.
    Tatro, A. R.
    Sun, D.
    VALUE IN HEALTH, 2018, 21 : S142 - S142